Manhattan Associates director plans $329K share sale
The notice lists 58,061,893 Manhattan Associates common shares outstanding alongside the proposed sale details.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Manhattan Associates director Linda T. Hollembaek filed a notice to sell 1,315 common shares, with an approximate sale date of November 3, 2026, and an aggregate market value of $328,750.00. The shares are identified as 161 shares from restricted stock vesting on May 12, 2022, and 1,154 shares from vesting on May 13, 2025. The notice lists her sale of 1,579 shares on August 6, 2026, for $299,820.68 during the prior three months.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting Under a Registered Plan financial
Registered Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.